Athyrium Capital Management, LP — Q3 2018 13F Holdings

Name: Athyrium Capital Management, LP — 13F Holdings, Q3 2018
Creator: AlphaSMO
License: https://www.sec.gov/forms

CIK: 0001728001

Total reported value

$8.7B

Full holdings list this quarter

#	Ticker	Issuer	Asset Subclass	Weight	Weight Change	Shares Change
1	AEGR 2 08-15-19	Aegerion Pharmaceuticals	Stock-Other	77.33%	—	+40.29%
2	PTCT 3 08-15-22	Ptc Therapeutics INC	Stock-Healthcare	21.23%	—	-17.81%
3	HQ8F	Apollo Endosurgery INC	Stock-Other	1.44%	—	—

Position changes disclosed by Athyrium Capital Management, LP for the quarter ending Q3 2018, including ticker, issuer, weight change, shares change, and action
#	Ticker	Issuer	Weight Change	Shares Change	Action
1	AEGR 2 08-15-19	Aegerion Pharmaceuticals	+9.7%	+40.29%	Add
2	HQ8F	Apollo Endosurgery INC	-0.5%	—	Unchanged
3	PTCT 3 08-15-22	Ptc Therapeutics INC	-9.2%	-17.81%	Trim